RedHill Biopharma Ltd. (RDHL)
$0.49-5.77%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 4.90
- P/E (TTM)
- -3.58
- Short % float
- 9.26%
- Days to cover
- 1.6
- SI change
- -10.2%
- 1W
- +4.26%
- 1M
- -15.52%
- vs SPY 1W
- +5.24%
- vs SPY 1M
- -17.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS & VALIDATION
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 19
- GROWTH
- 31
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC124.0%
REV YoY-
ROE206.7%
EPS YoY-
ROA-1.7%
GROSS100
OP-2765
NET-150
[VALUATION]
P/E TTM-3.58
P/E FWD-
SECTOR PE20.48
INDUSTRY PE19.11
P/B0.36
P/FCF-
EV/EBITDA0.18
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E25.07
ALTMAN Z-
CURR RATIO0.34
ND/EBITDA-
BETA4.90
[BEST COMBO]VALIDATED · V5
ENTER · HOLD · EXIT · WAITOne next-open action from five signal families, published only when the held-out edge survives 20 bps costs.
Today's action with its out-of-fold profit factor, trade count and family votes.
[WHITE ARROW]FULL HISTORY
SELL
Directional consensus stays BUY or SELL until the model reverses; trades fill next session open.
PROFIT FACTOR0.6
TRADES56
[REGIME]FULL HISTORY
CRISIS
BULL or RECOVERY stays invested; BEAR or CRISIS exits at the next session open.
Profit factor and trade count for holding this symbol only in BULL or RECOVERY.
[EXHAUSTION]NOW
Whether buyers or sellers are stretched today, the latest release and its strength.
Company news
FAQ
- What is LOPJLB’s current signal on RDHL?
- LOPJLB’s latest quantitative signal on RedHill Biopharma Ltd. (RDHL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RDHL in?
- RedHill Biopharma Ltd. (RDHL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does RedHill Biopharma Ltd. (RDHL) do?
- RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointestinal medications: Movantik, which addresses opioid-induced constipation in adults experiencing chronic non-cancer pain; Talicia, used to treat Helicobacter pylori infections in adult patients; and…